Increased Risk for Developing Major Adverse Cardiovascular Events in Stented Chinese Patients Treated with Dual Antiplatelet Therapy after Concomitant Use of the Proton Pump Inhibitor

BACKGROUND: Some clinical studies have demonstrated that the proton pump inhibitor (PPI) could decrease clopidogrel platelet response and increase major adverse cardiovascular events (MACE) in white or black subjects. However, that remains to be determined in Chinese patients. In this study, we soug...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Zou, Jian-Jun, Chen, Shao-Liang, Tan, Jie, Lin, Ling, Zhao, Ying-Ying, Xu, Hai-Mei, Lin, Song, Zhang, Juan, Fan, Hong-Wei, Xie, Hong-Guang
Formato: Artigo
Idioma:Inglês
Publicado em: Public Library of Science 2014
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3885647/
https://ncbi.nlm.nih.gov/pubmed/24416326
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0084985
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados